Perkinelmer

The momentum for this stock is not very good. Perkinelmer is not a good growth stock. Perkinelmer is not very popular among insiders. Perkinelmer is a mediocre stock to choose.
Log in to see more information.
PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, foo...

News

Treasurer of the State of North Carolina Has $8.69 Million Holdings in PerkinElmer, Inc. (NYSE:PKI)
Treasurer of the State of North Carolina Has $8.69 Million Holdings in PerkinElmer, Inc. (NYSE:PKI)

Zolmax Treasurer of the State of North Carolina cut its holdings in PerkinElmer, Inc. (NYSE:PKI Get Rating) by 2.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 61,995 shares of the medical research companys stock after selling 1,871 shares ...\n more…

Royal London Asset Management Ltd. Raises Stake in PerkinElmer, Inc. (NYSE:PKI)
Royal London Asset Management Ltd. Raises Stake in PerkinElmer, Inc. (NYSE:PKI)

Zolmax Royal London Asset Management Ltd. raised its stake in PerkinElmer, Inc. (NYSE:PKI Get Rating) by 1.2% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 42,070 shares of the medical research companys stock after purchasing an additional 503 shares during the ...\n more…

PerkinElmer (NYSE:PKI) Releases  Earnings Results, Misses Expectations By $0.06 EPS
PerkinElmer (NYSE:PKI) Releases Earnings Results, Misses Expectations By $0.06 EPS

Ticker Report PerkinElmer (NYSE:PKI Get Rating) issued its earnings results on Thursday. The medical research company reported $1.01 EPS for the quarter, missing analysts consensus estimates of $1.07 by ($0.06), RTT News reports. PerkinElmer had a return on equity of 13.94% and a net margin of 14....\n more…

Nordea Investment Management AB Decreases Stake in PerkinElmer, Inc. (NYSE:PKI)
Nordea Investment Management AB Decreases Stake in PerkinElmer, Inc. (NYSE:PKI)

Ticker Report Nordea Investment Management AB lessened its stake in PerkinElmer, Inc. (NYSE:PKI Get Rating) by 7.7% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 7,232 shares of the medical research companys stock after selling 606 shares during the quarter. ...\n more…

PerkinElmer (NYSE:PKI) Posts Quarterly  Earnings Results, Misses Estimates By $0.06 EPS
PerkinElmer (NYSE:PKI) Posts Quarterly Earnings Results, Misses Estimates By $0.06 EPS

Zolmax PerkinElmer (NYSE:PKI Get Rating) announced its quarterly earnings results on Thursday. The medical research company reported $1.01 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.06), RTT News reports. The company had revenue of $674.87 million during the quarter...\n more…

PerkinElmer (NYSE:PKI) Shares Gap Down  After Earnings Miss
PerkinElmer (NYSE:PKI) Shares Gap Down After Earnings Miss

Ticker Report PerkinElmer, Inc. (NYSE:PKI Get Rating) shares gapped down before the market opened on Thursday following a dissappointing earnings announcement. The stock had previously closed at $124.55, but opened at $117.18. PerkinElmer shares last traded at $117.16, with a volume of 245,551 shares ...\n more…